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Small resting  B  lymphocytes are  activated when their cell surface  immuno- 
globulin (Ig) receptors interact with specific antigen or anti-Ig antibodies. Such 
a  receptor-ligand interaction leads to enlargement and proliferation of B  lym- 
phocytes. These activated B cells can subsequently mature into Ig-secreting cells 
in the presence of appropriate accessory cell signals (1-3). However, monovalent 
anti-Ig antibodies cannot induce B cell activation even though they can bind to 
the surface  Ig (4-7).  It has thus been concluded that membrane  Ig has to be 
cross-linked to induce early steps in B cell activation (membrane depolarization; 
8) as well as later steps (proliferation). There are several B cell mitogens as well 
as antibodies to B cell membrane components that stimulate B cell proliferation 
but probably interact with B cell surface moieties other than Ig (9-1 1). It is not 
clear if cross-linking of demonstrated or postulated receptor structures  is also 
essential for these agents to transform resting B cells into activated cells. 
Recently we have described a  model system in which a  monoclonal antibody 
(MAb) to a  murine B lymphocyte differentiation antigen (Lyb-2) triggers B cell 
activation (12).  We have shown that under serum-free culture conditions, MAb 
to the Lyb-2 molecule transform small B cells into blast cells and induce B cell 
proliferation. Here we investigate the possibility that this B cell activation process 
requires  cross-linking  in  addition  to  the  binding  of antibody  to  the  Lyb-2 
molecules. We have prepared  divalent F(ab')z fragments and monovalent Fab' 
fragments and tested their ability to induce B cell-specific blast transformation 
and proliferation.  Our results demonstrate that monovalent anti-Lyb-2 is suffi- 
cient to induce B cell enlargement and proliferation so we conclude that cross- 
linking of Lyb-2 molecules is unnecessary for B cell activation. 
Materials and Methods 
Animals.  DBA/2J and C3H/HeJ mice were obtained from The Jackson Laboratory, 
Bar Harbor, ME. BALB/c Icr mice were obtained from the Laboratory Animal Facility 
of the Institute for Cancer Research, Philadelphia, PA. 
Preparation of Antibodies.  Anti-Lyb-2 (~',bK) MAb was purified from ascites from mice 
bearing the hybridoma clone  10.1.D2  as described earlier (12). Anti-# antibodies were 
purified from the serum of goats immunized with the  mouse IgMK myeloma protein 
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PC8916.  Immune goat  sera  were  extensively absorbed  with  IgG1  and  IgG2a mouse 
myeloma proteins  to  remove anti-light  chain  antibodies.  Anti-u  antibody was affinity 
purified from the negatively absorbed antiserum on an HPCM27 IgMx column. Affinity- 
purified goat anti-# antibodies were passed over a protein A-Sepharose column at pH 8.5 
and the protein A-bound fraction was eluted with acid and concentrated. 
Preparation of  F(ab')~ and Fab'fragments.  Anti-Lyb-2 MAb and the protein A-binding 
fraction of goat anti-# antibodies were digested with pepsin at an enzyme to protein ratio 
of 1:50 at 37 °C for different time periods (13). The pepsin digest was analyzed on sodium 
dodecyl sulfate-polyacrylamide  gel electrophoresis (SDS-PAGE) to monitor the appearance 
of species with the molecular weight of F(ab')2 fragments. Digests containing appreciable 
amounts of such fragments were passed through a protein A-Sepharose column at pH 8.5 
to remove the intact antibody from the F(ab')2 fragments (14).  Material that did not bind 
the column was concentrated and  used as F(ab')2 fragments. This preparation had  no 
undigested  intact  antibodies  as  shown  by  SDS-PAGE  analysis.  Fab'  fragments  were 
prepared by reduction of F(ab')~ fragments with 0.02 M dithiothreitol at room tempera- 
ture for 1.0  h and then alkylated with 0.024 M iodoacetamide at 37°C for 15 rain (15). 
All  fragments were dialyzed against saline, 0.22-#m filter-sterilized, and stored at 4°C 
until further use. 
Cultures and  Media.  Spleen  cells  or  splenic  B  cell  preparations  (see  below)  were 
cultured in serum-free Iscove's/Ham's F12 medium (16) at 37 °C either at 2.5 x  106 cells/ 
ml in 24-well Costar 3424 plates (Data Packaging, Cambridge, MA) or at 5 ×  105 cells/ 
0.2  ml in 96-well Costar 3596  plates in a  5% CO~ atmosphere for 2-4 d.  Supernatant 
from concanavalin A-activated rat spleen cells (Con A SN) was prepared by culturing 5.0 
×  106 spleen cells in 1.0  ml serum-free Iscove's/Ham's F12 medium with 2.0 t~g/ml Con 
A for 24 h and collecting the SN.  Con A  SN was filtered and stored frozen at -20°C. 
Free Con A was blocked by the addition of 20 mM a-methylmannoside. 
Cell Separations.  Adherent  cells were depleted by incubating spleen cells in  60-mm 
plastic dishes for 1.0 h at 37°C in RPMI 1640 medium with 5% fetal calf serum and then 
passing the nonadherent cells through prewarmed Sephadex G-10 columns once or twice 
according to the procedure of Ly and Mishell (17). Depletion of adherent cells was assessed 
by staining for nonspecific esterase. Adherent cell-depleted populations contained <0.5% 
esterase-positive cells.  T  cells were depleted by treatment with monoclonal anti-Thy-l.2 
from  the  clone  13-4  (18)  and  monoclonal  anti-Lyt-2  from  the  clone  3.168  (19)  plus 
absorbed rabbit complement (Low-Tox M; Accurate Chemical & Scientific Corp., West- 
bury, NY). 
Assays for B Cell Activation and Maturation.  Two assays were used to measure early 
steps of B cell activation. First, the increase in the size of B cells was determined by flow 
cytometry. Spleen cells cultured with various antibody preparations for 2 d were harvested, 
washed,  and stained  with an  F(ab')~ fragment of a  fluoresceinated goat anti-mouse Ig 
(Cappel Laboratories, Cochranville, PA) to detect B cells and with ethidium bromide to 
detect dead cells. The forward light scatter of 25,000 viable B cells was determined. Small 
lymphocytes gave a unimodal light scatter distribution centered at channel 400 with the 
amplifier gain set at four and a 400 mW argon laser output. Cells with light scatter greater 
than channel 650 were defined as blast cells and their percentage calculated. A  second 
assay for B cell activation was for proliferation, which was determined by measuring the 
incorporation of/SH]thymidine (6.0 Ci/mM; New England Nuclear, Boston, MA) over a 
4-h period after 48 h of culture. Finally, maturation to antibody secretion was determined 
after the addition of Con A  SN by using the protein A plaque-forming cell  (PFC) assay 
(20) with rabbit anti-# antibodies added to detect IgM-secreting cells. 
Results and  Discussion 
Comparison  of the Ability  of Fab'  Fragments of Anti-u and Anti-Lyb-2.1  MAb to 
Induce Blastogenesis in Small B Cells.  To assess the importance of receptor cross- 
linking  in  an  early  step  of  B  cell  activation,  we  measured  the  increase  in  B 
lymphocyte volume after exposure to monovalent or divalent fragments of either 
anti-u (2 I) or anti-Lyb-2 antibodies. Spleen ceils were cultured with either F(ab')~ 1798  SUBBARAO  AND  MOSIER  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Monovalent Fragments of Anti-Lyb-2.1 MAb but not of Goat Anti-# Antibodies 
Induce Blast Transformation of B Lymphocytes 
Addition to culture* 
DBA/2 B cells  BALB/c B cells 
(Lyb-2.1)  (Lyb-2.2) 
[SH]Thymidine  [SH]Thymidine 
incorporation  !  incorporation  !  Percent blast cells* 
Control Ig  15.7 +  2,3  4,3 (1.09)  2.3 (1.25) 
Anti-Lyb-2A MAb  35.7 +  3.11  33,7 (1.0t)  2.5 (1.20) 
F(ab')2 anti-Lyb-2.1  MAb  29.0 +  4.9 i  27,1 (1.03)  3.8 (1.03) 
Fah' anti-Lyb-2.1  MAb  30.5 zl: 2.1 !  33.0 (1,00)  4.8 (1.19) 
F(ab')~ goat anti-#  43.0 +  4.6 !  503 (1,17)  29.3 (1.09) 
Fab' goat anti-#  17.3  ±  3.1  6,2 (1.11)  2.8 (1.03) 
* The antibodies and the fragments were used at a concentration of 50 #g/ml. 
* 2.5  ×  106 spleen cells  were cultured in  1.0 ml of lscove's/F12 serum-free medium for 48  h  at 
37°C in a  5% COs atmosphere. Blast cells  were enumerated by flow cytometry as described in 
Materials and Methods. 
! Spleen cells were cultured at the concentration of 5 x  10B/0.2  ml culture in serum-free Iscove's/ 
F12 medium in Costar 3596  plates. After 48 h, cultures were pulsed for 4  h  with  1.0 of [SH]- 
thymidine, harvested onto filter discs, and counted. Results are expressed as the geometric mean 
(× 10 -s) of values from triplicate cultures with SE in parentheses. 
i A  two-tailed Student's t test was used to evaluate the statistical significance of the percent blast 
cells in the experimental groups vs. the control lg group. Values indicated are significantly different 
from control lg with P <  0.05. 
or Fab'  fragments in serum-free Iscove's/Ham's F12 medium for 48 h and the 
number of B cell blasts was determined as described in Materials and Methods. 
As can  be seen  from  Table  I,  both  F(ab')9 and  Fab'  fragments  of anti-Lyb-2 
MAb were able to induce a substantial fraction of B cells to increase in size and 
the antibody fragments were nearly as effective as the intact antibody. Only the 
surface Ig  ÷ lymphocytes were stimulated to blast transformation in these cultures 
(data not shown) and the response was restricted to Lyb-2.1 ÷ strains.  In contrast 
to these results, monovalent Fab' fragments of goat anti-# antibodies were unable 
to increase the percent of B cell blasts in these serum-free cultures even though 
the F(ab')2 anti-, was very effective in inducing the blast cell transformation  of 
B cells. The viability of the cells after 2 d of culture in serum-free medium was 
similar in all groups and ranged from 70 to 80%.  Further,  the recovery of cells 
did not vary significantly in the different groups, suggesting that these effects of 
antibody fragments are due to induction of blastogenesis rather than the selective 
survival of blast cells in the critical groups. 
B  Cell Proliferation  Is Induced  by the Fab'  Fragment of Anti-Lyb-2 MAb.  We 
have shown previously (I 2) that  intact anti-Lyb-2.1  MAb induces B cell prolif- 
eration.  Since the monovalent antibody fragments were able to activate B cells 
into blast cells, we investigated if they would induce proliferation and if the Fab' 
fragments retained the specificity for the Lyb-2.1 allele. Results in Table I show 
that  this  indeed  is the case;  that  is,  Fab' anti-Lybo2 induced  DBA/2 B cells to 
proliferate to at least the same extent as the intact antibody. As expected (4-6), 
the F(ab')2 anti-# but not the monovalent  Fab anti-#  was able to induce prolif- 
eration. Since the proliferation induced by Fab' anti-Lyb-2.1 MAb in the BALB/ 
c spleen cells (Lyb-2.1-) was slightly above background, it was formally possible 
that  the fragment contained very low levels of contamination  with lipopolysac- 
charide (LPS). This explanation  seems to be unlikely for two reasons. First,  the 
extent of proliferation  induced  by the  Fab'  or anti-Lyb-2.1  MAb in  the  LPS- SUBBARAO  AND  MOS1ER  BRIEF  DEFINITIVE  REPORT  1799 
unresponsive C3H/HeJ  (Lyb-2.1-) mice was of almost the same magnitude as 
observed with BALB/c mice (data not shown). Second, the dose-response rela- 
tionships for intact antibody and Fab'  fragments are similar (data not shown). 
We think it is unlikely that the biologic effects of Fab' fragments of anti-Lyb-2.1 
MAb can be attributed to redimerization of the reduced and alkylated fragments. 
Gel  electrophoresis of Fab'  fragments of anti-Lyb-2.1  under  nondenaturing 
conditions showed no evidence of any higher molecular weight species. The lack 
of activity of Fab' anti-# demonstrates that goat Fab' fragments do not dimerize 
under  our  serum-free  culture  conditions,  and  we  assume  that  mouse  Fab' 
fragments behave similarly. Finally, Dower, Ozato, and Segal (22) have shown 
functional monovalency of mouse Fab' fragments prepared by methods identical 
to ours. 
The nature of B cell activation achieved by the Fab' anti-Lyb-2.1  MAb or by 
the whole antibody appear to be similar, since in both cases the activated B cells 
mature into Ig-secreting cells in the presence of factors from Con A SN (Table 
II). Once again, monovalent fragments of anti-~ did not synergize with Con A 
SN to induce polyclonal activation of B cells.  Fab'  anti-~ antibody did have a 
negative influence in that the background response in the presence of Con A SN 
alone was diminished substantially. The small response to the fragments of anti- 
Lyb-2 antibody alone (i.e., in the absence of Con A  SN) may be due to direct 
activation of a small number of preactivated cells in the cultures. 
Cellular  Requirements  for  the  Proliferation  Induced  by  Fab'  of anti-Lyb-2.1 
MAb.  Even though the Fab'  fragments of anti-Lyb-2.1  MAb cannot cross-link 
the Lyb-2 molecules by themselves, it is possible that they may do so with the 
assistance of accessory cells such as adherent cells or T  cells. This possibility was 
tested by evaluating the ability of Fab'  anti-Lyb-2.1  MAb antibody to induce 
proliferation in spleen cells that were depleted of T  cells or adherent cells. The 
proliferation induced by the Fab' fragment of the anti-B cell MAb was not at all 
diminished by the removal of the adherent cells or T  cells, suggesting that the B 
cells are being stimulated directly by the monovalent antibody fragments (data 
not shown).  By contrast the same T-depleted or adherent cell-depleted cells 
were substantially reduced in their proliferative response to concanavalin A. 
Our results demonstrate that monovalent Fab' fragments of anti-Lyb-2.1 are 
at least as effective as the intact antibodies in stimulating a fraction of normal B 
cells to become blast  cells and another or the same fraction to proliferate.  It 
appears unlikely that monomeric anti-Lyb°2 fragments are indirectly aggregated 
at the surface of an accessory cell, since the Fab' fragments appear to be effective 
in the apparent absence of T  cells and adherent cells. In addition, we have direct 
evidence to show that apparently normal numbers of Lyb-2 molecules are still 
detectable on spleen cells after in vitro culture with intact anti-Lyb-2.1 MAb for 
24  h  (our  unpublished  observations),  suggesting  that  the  antibody  does  not 
induce Lyb-2 aggregation and endocytosis or shedding.  It appears that in this 
system, receptor occupancy is  sufficient to  provide  an  activation  signal  to  B 
lymphocytes and that cross-linking of receptors or receptor modulation is not 
required. It is possible that monovalent or divalent antibody binding to Lyb-2 
activates  local  aggregation  via  an  allosteric  effect  on  the  membrane-bound 
domain of Lyb-2. We thus can be confident that cross-linking of Lyb-2 is not a 
requirement for B cell activation, but local aggregation of Lyb-2 molecules by a 1800  SUBBARAO  AND  MOSIER  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
B Cells Activated  by Monovalent Anti-Lyb-2.1  MAb but Not by 
Monovalent Anti-# Antibody Mature into Antibody-secreting Cells in 
the Presence of Factors from Con A SN 
Antibody  in the culture* 
Protein A PFC/culture 
Medium alone  With serum-free  Con 
A SN* 
Control lg  21 (1.14)  270 (1.30) 
Anti-Lyb-2.1 MAb  90 (1.08)  3,130 (1.03) 
F(ab')~  anti-Lyb-2.1 MAb  165 (1.14)  2,154 (1.10) 
Fah' anti-Lyb-2.1 MAb  263 (1.05)  1,943 (1.10) 
F(ab')2  goat anti-#  10 (1.20)  3,112 (1.03) 
Fab' goat anti-•  8 (1.01)  47 (1.75) 
LPS (10 t~g/ml)  5,131 (1.20)  7,421 (1.17) 
LPS (0.01 #g/ml)  86 (1.16)  383 (1.04) 
5 × 105 DBA/2 spleen cells were cultured in serum-free Iscove's/Fl  2 medium. 4 d 
later, Ig-secreting  cells were measured by the techniques of Gronowicz  et al. (20). 
Results are expressed  as the geometric mean of triplicate  cultures (x/+ SE). 
* Antibodies  and their fragments were used at 50 g.g/ml concentration. 
* Con A SN is made by stimulating  spleen  ceils  with 2 #g]ml Con A for 24 h in serum- 
free medium. 20 mM a-methyl mannoside  is added to Con A SN to block free Con 
A. 
mechanism  not dependent  on muhivalent ligands cannot be excluded. 
Do Lyb-2 molecules have a  functional role in the physiology of B  lymphocytes? 
Based on  the analogy that anti-receptor antibodies may mimic the action of the 
ligand that binds the receptor,  we suggested (12)  that  Lyb-2 is a  receptor  for a 
B  cell growth  factor (12).  It seems  unlikely that small molecular weight ligands 
can  induce  receptor  cross-linking unless binding takes place in the context of a 
large,  muhivalent  carrier molecule.  We thus  assert that  functional activity as a 
monovalent  ligand might be expected of a  small, polypeptide growth factor, and 
that Lyb-2 should be viewed tentatively as a  receptor in search of its ligand. 
Summary 
Although activation of B ]ymphocytes by antigen or anti-Ig antibody has been 
shown  to  require  cross-linking  of surface  Ig  molecules,  cross-linking  is  not 
necessary for B cell activation by anti-Lyb-2 monoclonal antibody (MAb). Mon- 
ovalent Fab' fragments of anti-Lyb-2 MAb are as effective as the intact antibody 
in inducing blast cell transformation of small B cells and B cell proliferation in 
the apparent absence of T  cells and adherent cells.  In the presence of factors 
from  T  cells,  B  cells  activated  by  Fab'  fragments of anti-Lyb-2  MAb  were 
induced  to  mature  into  Ig-secreting cells.  Since  monovalent  Fab'  fragments 
probably cannot induce receptor aggregation, it appears that receptor occupancy 
is sufficient to induce B cell activation with anti-Lyb-2 MAb. 
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